🇺🇸 FDA
Patent

US 9388247

Antibodies against cancer target block tumor growth, angiogenesis and metastatis

granted A61KA61K2039/505A61P

Quick answer

US patent 9388247 (Antibodies against cancer target block tumor growth, angiogenesis and metastatis) held by The Regents of the University of California expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61P, A61P13/08, A61P13/10